Neuropathic Ocular Pain Market Growth Accelerated by Rising Awareness about Neuropathic Ocular Pain Treatment


 Neuropathic ocular pain occurs due to damage or dysfunction of peripheral and central pain pathways in eyes. It can cause burning sensation, stabbing pain or altered sensation in eyes. Drugs such as pregabalin and gabapentin are commonly used to alleviate neuropathic ocular pain. These drugs help restore the altered neuronal activity and reduce pain signals from eyes to brain. The global Neuropathic Ocular Pain Market is estimated to be valued at US$ 197.1 Mn in 2024 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
Rising awareness about neuropathic ocular pain treatment is driving the market growth significantly. Various awareness programs conducted by government as well as private organizations regarding identification and management of neuropathic pain have positively impacted the market. Campaigns on social media platforms also play a vital role in spreading information about latest treatment options. As a result of such initiatives, large number of patients are now able to recognize symptoms of neuropathic ocular pain and seek timely clinical evaluation and prescription drugs. This rising awareness has increased demand for neuropathic ocular pain drugs over the forecast period.

Segment Analysis
The global neuropathic ocular pain market is dominated by chronic pain segment. Chronic pain segment comprises pain associated with conditions such as post herpetic neuralgia and diabetic nephropathy. This segment accounts for over 60% share of the global market owing to increasing incidences of underlying conditions leading to neuropathic ocular pain such as diabetes and herpes zoster.

Key Takeaways
The global neuropathic ocular pain market is expected to witness high growth over the forecast period of 2023-2030.

Regional analysis: North America currently dominates the global market and is expected to maintain its dominance over the forecast period. High prevalence of diabetes and increasing adoption of novel drugs for treatment of neuropathic pain are major factors contributing to market growth in the region. Asia pacific is expected to be the fastest growing market owing to increasing healthcare expenditure, large patient pool and growing awareness regarding management of chronic pain.

Key players operating in the neuropathic ocular pain market are Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline plc., Depomed Inc., GlaxoSmithKline plc. Pfizer Inc. dominates the global market owing to its strong portfolio of drugs for treating neuropathic pain conditions. Eli Lilly and Company holds significant market share due to its leading drug Cymbalta for diabetic peripheral neuropathy.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more